William Blair Reaffirms Outperform Rating on Rocket Pharma Despite Trial Setback
Sami Corwin, an analyst at William Blair, maintained his Outperform rating on Rocket Pharmaceuticals Inc. (NASDAQ:RCKT) on May 27 with…
Tag: reaffirms
Benchmark Reaffirms Buy on TAT Technologies (TATT) After Major MRO Deal
Benchmark analysts reaffirmed their Buy rating on TAT Technologies Ltd. (NASDAQ:TATT) and maintained a $35 price target on May 23,…
JMP Reaffirms Market Outperform Rating on Workday After Mixed Q1 Report
JMP analysts gave Workday Inc. (NASDAQ:WDAY) a Market Outperform rating on May 23, along with a stable price target of…
Paul Atkins reaffirms crypto commitments
SEC Chairman Paul Atkins issued a sharp critique of the agency’s past crypto strategy, calling it ineffective and damaging to…